Kopran Limited

Kopran Limited (KOPRAN) is a micro-cap Healthcare company valued at ₹1,310 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Kopran Limited last traded at ₹271.2, down 4.49% on the day.

Recent developments

On 2026-08-11, the company announced a dividend of ₹3.00 per share, with the ex-date set for the same day. The foreign institutional holding decreased by 0.06 percentage points to 0.51% as of 2026-06-30. The company reported a net profit of ₹7 crore in the latest quarter, following a net profit of ₹19 crore in the previous quarter.

Financial performance

The company's annual revenue rose 8.2% to ₹681 crore, but net profit fell 34.0% to ₹26 crore. In the latest quarter, revenue grew 13.9% to ₹154 crore, while net profit remained flat at ₹7 crore compared to the same quarter a year earlier. The net profit margin narrowed to 3.8% from 6.2% a year ago, and return on equity was 0.0%.

Valuation multiples

The stock trades at 50.9 times earnings, a premium to the Healthcare median of 32.0, 2.15 times book value. It yields 1.3%.

Things to watch

The company's net profit margin has declined by 2.4 percentage points to 3.8%, and return on equity is 0.0%, indicating weak profitability. The stock is 4.7% below its 52-week high, and net profit fell 34.0% annually. The latest quarter's net profit was flat compared to the same quarter a year earlier, despite revenue growth.

Where it stands

Kopran Ltd's revenue grew 8.2% annually, but net profit dropped 34.0%, with the net profit margin narrowing to 3.8%. The stock is 4.7% below its 52-week high, and the latest quarter's net profit was flat despite revenue growth. The company's return on equity is 0.0%, and the foreign institutional holding decreased by 0.06 percentage points.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.